newsfilter
← Latest News
Business Wire·

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the results from its annual and special meeting of shareholders